Følg feeder: blogger, nyheter, RSS og mer. En enkel måte å lese og fordøye innholdet du velger selv.
Få FeederRSS-strømmene om Aksjemarkedet som Feeder-brukere følger mest, inkludert JPX マーケットニュース, BioCryst Pharmaceuticals News Releases og ntv.com.tr. Kopier nettadressen til en strøm, eller følg dem gratis i Feeder.
Finans RSS-feeder Investering RSS-feeder Privatøkonomi RSS-feeder Bankvirksomhet RSS-feeder
Foreslå en endringNTV Haber - Türkiye ve Dünya Gündemi Güncel Son Dakika Haberleri - Editörün Seçimi
China economy news, including budget, the stock market and analysis.
Contains the last 20 releases
致力於整合全球總經數據,試圖發覺景氣循環的蛛絲馬跡,相信所有金融商品的投資決策都應回歸基本面。期待協助大家找到屬於自己的投資地圖!
This feed is responsible for generating the rss feed related to the topic markets
National Stock Exchange- SHAREHOLDING PATTERNS
© seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (https://about.seekingalpha.com/terms). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited.
MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products.
The top News headlines from The Sydney Morning Herald. For all the news, visit https://www.smh.com.au
מידע עסקי מעודכן במגוון נושאים: הבורסה בתל אביב, וול סטריט ושוקי עולם, ביטוח ופיננסים, הייטק, צרכנות, משפט ועוד
Stock Market and Investing Blog of Meb Faber
Tạp chí kinh tế Việt Nam và Thế Giới
מידע עסקי מעודכן במגוון נושאים: הבורסה בתל אביב, וול סטריט ושוקי עולם, ביטוח ופיננסים, הייטק, צרכנות, משפט ועוד
Read all about personal finance, mutual funds, gold price today, share market tips, stock news, BSE and NSE India, insurance etc. See currency converter on dollar to rupee & rupee to all international market indices and more.
© seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (https://about.seekingalpha.com/terms). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited.